Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

被引：14
|
作者：
Buti, Sebastiano [1 ]
Bersanelli, Melissa [1 ]
机构：
[1] Univ Hosp Parma, Parma, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 16期
关键词：
TRIAL; THERAPY;
D O I：
10.1200/JCO.2016.71.6506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1858 / +
页数：2
相关论文
共 50 条
  • [31] COST EFFECTIVENESS OF SUNITINIB AS FIRST-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA IN CHINA
    Shi, Q.
    Yin, H.
    Xuan, J.
    Wu, Y.
    Cheng, G.
    VALUE IN HEALTH, 2014, 17 (07) : A638 - A638
  • [32] Bevacizumab - In first-line treatment of advanced and/or metastatic renal cell carcinoma
    Frampton, James E.
    Keating, Gillian M.
    BIODRUGS, 2008, 22 (02) : 113 - 120
  • [33] BevacizumabIn First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
    James E. Frampton
    Gillian M. Keating
    BioDrugs, 2008, 22 : 113 - 120
  • [34] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [35] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Ruiz-Morales, Jose Manuel
    Swierkowski, Marcin
    Wells, J. Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Sliwczynsk, Andrzej
    Ptak-Chmielewska, Aneta
    Teter, Zbigniew
    Beuselinck, Benoit
    Wood, Lori A.
    Yuasa, Takeshi
    Pezaro, Carmel
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 102 - 108
  • [36] Cost-Effectiveness of Nivolumab Plus Cabozantinib Versus Sunitinib as a First-Line Treatment for Advanced Renal Cell Carcinoma in the United States
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] The effect of age on first-line sunitinib treatment in patients with renal cell carcinoma (RCC).
    Coward, J. I. G.
    Larbi, E. D.
    Pandha, H. S.
    Michael, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment
    Kammerer-Jacquet, Solene-Florence
    Brunot, Angelique
    Benasalah, Karim
    Campillo-Gimenez, Boris
    Lefort, Mathilde
    Bayat, Sahar
    Ravaud, Alain
    Dupuis, Frantz
    Yacoub, Mokrane
    Verhoest, Gregory
    Mathieu, Romain
    Peyronnet, Benoit
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Bernhard, Jean-Christophe
    Rioux-Leclercq, Nathalie
    LABORATORY INVESTIGATION, 2017, 97 : 234A - 234A
  • [39] Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment
    Kammerer-Jacquet, Solene-Florence
    Brunot, Angelique
    Benasalah, Karim
    Campillo-Gimenez, Boris
    Lefort, Mathilde
    Bayat, Sahar
    Ravaud, Alain
    Dupuis, Frantz
    Yacoub, Mokrane
    Verhoest, Gregory
    Mathieu, Romain
    Peyronnet, Benoit
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Bernhard, Jean-Christophe
    Rioux-Leclercq, Nathalie
    MODERN PATHOLOGY, 2017, 30 : 234A - 234A
  • [40] Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
    Kammerer-Jacquet, Solene-Florence
    Brunot, Angelique
    Bensalah, Karim
    Campillo-Gimenez, Boris
    Lefort, Mathilde
    Bayat, Sahar
    Ravaud, Alain
    Dupuis, Frantz
    Yacoub, Mokrane
    Verhoest, Gregory
    Peyronnet, Benoit
    Mathieu, Romain
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Bernhard, Jean-Christophe
    Rioux-Leclercq, Nathalie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 603.e7 - 603.e14
12345